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0·5 mg., is given intravenously with the crowning of the
foetal head and an active delivery of the placenta (Brandt
Andrew technique) or controlled cord traction, is under-
taken.
Follow-up Management
An attempt to arrive at an accurate diagnosis of the
cause of prolonged labour must be made since it can
affect the patient's management in subsequent pregnancies.'
A postpartum X-ray pelvimetry is often of tremendous
value.
Management of the Newborn Foetus
These infants have an increased chance of having at
birth, or developing soon after birth, an intracranial
haemorrhage or pulmonary infection. They should be cot-
nursed and critically observed for at least 24 hours. Vita-
min-K analogue, I mg. intramuscularly, is given soon after
birth. Where there is a probability of infection being pre-
sent antibiotics are given.
SUMMARY
Any labour that lasts for more than 36 hours is abnormally
prolonged. There is no place for domiciliary treatment: the
patient must be admitted to an institution where all operative
procedures pertaining to obstetrics and adequate resuscitation
of the newborn can be performed. General measures to relieve
pain, and to correct dehydration and ketosis are necessary in
all cases.
If absolute cephalo-pelvic disproportion or foetal distress is
present, the labour should immediately be terminated by
caesarean section. All other cases can be treated expectantly,
in the hope of achieving a vaginal delivery, for a further arbi-
trary period which will vary from case to case and which will
depend mainly on any progress in the labour, assessed by
further dilatation of the cervix.
If there has been inertia during the first and second stage,
it may continue into the third stage with the risk of post-
partum haemorrhage. Ergometrine, 0·5 mg. intravenously, is
then given with the crowning of the foetal head and active de-
livery of the placenta (Brandt Andrew technique) or controlled
cord traction is undertaken.
I wish to express my sincere thanks to Dr. C. J. T. Craig
for his helpful criticism and advice in the preparation of this
paper.
REFERENCES
1. Craig. C. J. 1. (1961): S. Afr. Med. J., 35.878.
2. Johnson, G. T. (1957): Brit. Med. J., 2, 386.
3. Cooper. J. K. and Moir. J. C. (1963): Ibid., I, 1372.
4. Buss, T. St. V. (1965): S. Afr. J. Obstet. Gynaec., 3, 53.
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Obstetrics and Gynaecology, Universiry of Cape Town
Clomiphene citrate has only been available at the gynae-
cological endocrine clinic, Groote Schuur Hospital, since
the early part of 1965. The following is a case report of
a successful pregnancy following induction of ovulation
by means of this drug.
CASE REPORT
Mrs. V.B., a White female, aged 29 years, gravida 0,
para 0, presented on 3 June 1964 with a history of secon-
dary amenorrhoea for 8 months and primary infertility for
3 years.
The menarche had occurred at the age of 12, and the
cycle had been 10 - 14/30 - 120 days since that time. The
flow had been normal with no associated abdominal pain.
A wedge resection of the ovaries in 1963 restored the cycle
to a 5 - 8/30 - day one, for 7 months. Since then there has
been complete amenorrhoea. Breast, pubic and axillary
hair developed at the age of approximately 12 years.
Past hisrory. A diagnostic premenstrual curettage in
1960 had shown endometrial hyperplasia, absence of secre-
tory activity, and no tuberculous endometritis. In 1963 an
endometrial biopsy showed the same findings as above,
and wedge resection of the ovaries was performed in
April 1963. The ovaries were It times normal size. not
typical in appearance of hyperthecosis ovarii. Histological
examination showed multiple follicular cysts with some
luteinization of the theca interna but not all the features
of the Stein-Leventhal syndrome. The patient also had
psoriasis treated with systemic cortisone in 1961.
The family history showed no evidence of tuberculosis
or diabetes. The patient's weight has been constant and
there were no symptoms related to the thyroid or pan-
creatic glands. She was happily married and no psycho-
logical factors seemed to be present.
On examination she had a normally developed female
appearance with all secondary sex characteristics present.
There was no evidence of obesity or hirsutism. Systematic
examination showed no abnormality.
Pelvic examination showed a normally developed vulva
and clitoris. The uterus was normal in size and position.
The ovaries could not be palpated and the cervix Was
healthy.
Special invesrigatiol1s. Cytology was normal and the cornifi-
cation index was 6%. Progesterone withdrawal test-norethis-
terone 5 mg. r.d.s. for ID days followed 14 days later by 5 - day
bleed. For endometrial and ovarian histology see past history.
Pituitary gland examination showed fundi and visual fields
to be normal; X-ray of pituitary fossa was normal; FSH was
6 m.u. Adrenals-the 17 - ketosteroids were 14·0 mg./24 hrs.
and the 17 - hydroxycorticosteroids 9·2 me;. /24 hrs. Thyroid
function - serum cholesterol 223 mg./lOO ml.; 1311 uptake,
51 % of dose in 24 hrs., and RBC uptake, 16·8% of dose in
24 hrs., were both normal. Pancreatic function-the urine con-
tained no glucose, and the OTT was normal.
X-ray of the chest was normal.
Blood investigations - haemoglobin 13·3 G./lOO m!.; PCV
40%; MCHC 33%; WBC 4,120/cu.mm. The liver-function
test was normal.
Infertility tests-both seminal analysis and hysterosalpingo-
gram was normal.
Conclusion. It would appear that failure to ovulate was
due to a primary pituitary gonadotrophic failure. Follicular
function is present (oestrogen).
TREATMENT
Pergonal (FSH from postmenopausal human urine), 500
mg./day intramuscularIy for 10 days, followed by Pregnyl
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(human chorionic gonadotrophins containing mainly LH
and LTH), 6,000 units a day for 4 days, were given, com-
mencing on 15 January 1965.
On this regime the Cl rose from 6% to a maximum of
58°:', 12 days after commencing treatment. Ferning of the
cervical mucus which was present at day 10, gradually dis-
appeared after day 18, and there was a rise in basal body
temperature on day 12 which was maintained until she had
a 5 - day period, 26 days following commencement of
therapy. Because of limited supplies of Pergonal it was
decided to change therapy to Clomiphene.
Clomiphene citrate, 100 mg./day for 5 days, was com-
menced on 10 May 1965. On this treatment cornification
rose from 4% to 9% on day 13; only slight ferning was
present 2 days following the start of therapy and had dis-
appeared by day 14; there was pain in the right iliac fossa
on day 12 (? Mittelschmerz); a rise in basal body tempera-
ture occurred on day 14. The patient conceived during this
cycle. She suffered no side-effects other than the above
pain.
Progress of Pregnancy
Antenatal. 0 obvious hormonal insufficiency in early
pregnancy as evidenced by low Cl and absence of ferning.
Failure of weight gain from 30 weeks gestation onwards-
? slow growth of foetus.
Labour. Artificial rupture of membranes undertaken
at 39 weeks because of loss of weight (2 lb.) from 38 to 39
weeks. Induction-delivery interval 5 hrs. Normal amount
and colour of liquor and normal delivery.
The puerperium was uneventful. Normal lactation was
well maintained. The infant was a female weighing 7 lb.
3 oz., and was normal. The placenta was macroscopically
normal.
DISCUSSION
Clomiphene citrate is an analogue of the non-steroid oes-
trogen chlorotrianisene. The precise method of action is
unknown. It may act directly on ovarian steroidogenesis.'
By acting on cytochrome C reductase in the ovary, this
substance is reduced with resultant speeding up of the
conversion of triphosphopyridine nucleotide (TPN) to its
reduced state, dihydrophosphopyridine nucleotide (TP rH).
The latter causes the aromatization reaction with increased
secretion of oestradiol and oestrone. On the other hand
its action may be primary at pituitary or hypothalamic
level.'
It may compete with natural oestrogens for binding
sites in the above organs, so displacing it and its inhibitory
effects on these parts. A similar effect may operate at the
peripheral sites, e.g. uterus.
Seleciion of Patients
(i) Anovulatory patients with adequate endogenous oes-
trogen secretion and normal thyroid and adrenal function.
Results are much better in the presence of a proliferative-
or, even better, hyperplastic--endometrium than when the
endometrium is atrophic.
(ii) Normal or reduced pituitary gonadotrophins. How-
ever, Clomiphene will have no effect in the presence of
complete pituitary failure.
(iii) Stein-Leventhal Syndrome.' Most of these patients
will exhibit an ovulatory response to Clomiphene.
Dosage
The dose depends on the type of patient being treated,
and the sensitivity of the ovary. Prior priming with oes-
trogen is not necessary. The initial dose is usually 50 mg./
day for 3 - 5 days. If the ovaries are resistant, the dosage is
increased but rarely exceeds 600 mg. per treatment cycle.
If withdrawal bleeding occurs, therapy is again com-
menced 10 - 14 days following the first day of the bleed.
In the absence of any response, the second course is com-
menced after 30 days. At least 6 consecutive cycles of
therapy should be given before concluding that the patient
is a 'Clomiphene failure'.
Side-Effects
Ovarian CySTS.' These are cystic follicles and cystic cor-
pora lutea. Patients receiving Clomiphene should be
watched constantly for the development of ovarian cysts.
These usually regress spontaneously within 7 - 28 days.
The presence of an ovarian cyst before treatment con-
traindicates the use of the drug. In those patients who have
had previous ovarian cystectomies, initial dosages must be
very low. Hot flushes are not serious and disappear when
therapy is discontinued.
Abdominal pain at the time of ovulation is common.
Blurring of vision and spots of light have been noticed
but no organic abnormalities have been found. Loss of
hair is of a temporary nature and is never severe.
Clomiphene should not be used in the presence of pre-
existing liver disease.
ResulTs
Of a total of 1,731 3 patients treated for various indica-
tions, 70°0 had one or more ovulatory cycles. Ovulation
occurred after the first course of treatment in 77~~. In
16% ovulation only occurred after 2 or more courses. The
best response (78%) was obtained in patients with the
Stein-Leventhal syndrome. Pregnancy followed in 28°b of
those patients who ovulated.' However. many of these
patients were single and others were not desirous of
pregnancy.
Multiple pregnancy is more common (± 8%). This is
similar to Gemzell's' findings in patients treated with
human pituitary gonadotrophins.
There is no increase in congenital abnormalities.
SUMMARY
A case of anovulation successfully treated with Clomiphene is
described. It is essential, firstly, to prove anovulation and
then to make an extensive search for its many possible causes.
Clomiphene will only benefit a small, selected group of
patients.
I wish to thank Dr. C. J. T. Craig for his efforts in obtaining
the drug, and the Wm. S. Merrell Company for making
Clomiphene available to us. I should also like to thank Dr.
J. G. Burger, Medical Superintendent of Groote Schuur Hos-
pital. for permission to publish the case.
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